We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Kratos Defense & Security Solutions
KTOS
$10.9B
| $2.19M | ﹤0.01% |
121,575
+1,723
| +1% | +$32K |
|
1752
Ubiquiti
UI
$34.3B
| $2.19M | ﹤0.01% |
11,589
-3,106
| -21% | -$501K |
|
1753
Advanced Drainage Systems
WMS
$11.3B
| $2.19M | ﹤0.01% |
56,365
+7,789
| +16% | +$288K |
|
1754
Sunrun
RUN
$2.24B
| $2.19M | ﹤0.01% |
158,292
+6,689
| +4% | +$99.7K |
|
|
IPHS
1755
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.18M | ﹤0.01% |
68,280
+3,618
| +6% | +$116K |
|
1756
Element Solutions
ESI
$9.42B
| $2.18M | ﹤0.01% |
186,807
+879
| +0.5% | +$9.7K |
|
1757
QuinStreet
QNST
$873M
| $2.18M | ﹤0.01% |
142,181
+7,799
| +6% | +$111K |
|
1758
JELD-WEN Holding
JELD
$155M
| $2.17M | ﹤0.01% |
92,719
+1,310
| +1% | +$27K |
|
|
SRG
1759
Seritage Growth Properties
SRG
$136M
| $2.17M | ﹤0.01% |
54,010
+2,016
| +4% | +$85.4K |
|
|
GLUU
1760
DELISTED
Glu Mobile Inc.
GLUU
| $2.16M | ﹤0.01% |
357,405
+204,840
| +134% | +$1.17M |
|
|
VISN
1761
Vistance Networks Inc
VISN
$2.3B
| $2.16M | ﹤0.01% |
152,283
+397
| +0.3% | +$5.15K |
|
|
NGHC
1762
DELISTED
National General Holdings Corp
NGHC
| $2.16M | ﹤0.01% |
97,798
+1,054
| +1% | +$23K |
|
|
MIK
1763
DELISTED
Michaels Stores, Inc
MIK
| $2.16M | ﹤0.01% |
266,986
+8,610
| +3% | +$72.3K |
|
1764
OneMain Financial
OMF
$7.49B
| $2.16M | ﹤0.01% |
51,142
+333
| +0.7% | +$13.5K |
|
1765
Matrix Service
MTRX
$329M
| $2.15M | ﹤0.01% |
94,207
+6,603
| +8% | +$130K |
|
|
CCXI
1766
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.15M | ﹤0.01% |
54,374
+7,763
| +17% | +$136K |
|
1767
Spectrum Brands
SPB
$2.05B
| $2.15M | ﹤0.01% |
33,410
-9,405
| -22% | -$533K |
|
1768
DMC Global
BOOM
$155M
| $2.14M | ﹤0.01% |
47,643
+4,016
| +9% | +$179K |
|
|
HSKA
1769
DELISTED
Heska Corp
HSKA
| $2.13M | ﹤0.01% |
22,258
+1,344
| +6% | +$116K |
|
1770
Editas Medicine
EDIT
$450M
| $2.13M | ﹤0.01% |
71,873
+6,114
| +9% | +$153K |
|
1771
Moelis & Co
MC
$5.07B
| $2.12M | ﹤0.01% |
66,538
+5,605
| +9% | +$184K |
|
1772
Kodiak Sciences
KOD
$2.84B
| $2.12M | ﹤0.01% |
29,488
+5,945
| +25% | +$216K |
|
1773
Talos Energy
TALO
$2.36B
| $2.11M | ﹤0.01% |
70,076
+35,839
| +105% | +$837K |
|
|
WCC
1774
WESCO International
WCC
$18.1B
| $2.11M | ﹤0.01% |
35,550
+182
| +0.5% | +$9.49K |
|
|
TPTX
1775
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.11M | ﹤0.01% |
33,834
+27,105
| +403% | +$1.29M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.